The third edition (November 2024) of the dataset for histopathological reporting of breast disease in surgical excision specimens of breast cancer has now been published by RCPath.
Key updates include an expansion to the section on macroscopic handling of specimens, inclusion of LCIS variants and new WHO histological subtypes. A section on male breast disease has been added, and information included on reporting ER low carcinomas.
Helpful new appendices provide advice on assessing tumour cellularity for molecular testing and information on emerging prognostic and biomarker assays.
コメント